10X Genomics Inc vs Vale SA — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vale SA trades at $14.13 (market cap $59.07B). The key difference: Vale SA is far larger — about 10.8× 10X Genomics Inc's market cap, and Vale SA pays a 8.93% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | VALE | |
|---|---|---|
Market Cap | $5.48B | $59.07B |
Sector | Health | Basic Materials |
52-Week High | $45.80 | $17.82 |
52-Week Low | $11.34 | $9.53 |
Enterprise Value | $5.02B | $75.99B |
Dividend Yield | — | 8.93% |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →